Bintang Mitra Semestaraya Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bintang Mitra Semestaraya Tbk trades at Rp302 (market cap 357.03B, 33.4K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bintang Mitra Semestaraya Tbk and Diagnos Laboratorium Utama Tbk. are close in size by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 33.4K). Which is the better fit depends on your goals.
| BMSR | DGNS | |
|---|---|---|
Market Cap | 357.03B | 310.75B |
Volume | 33.4K | 963.6K |
Lot | 334 | 9.64K |
Turnover | 10.18M | 217.67M |
Average Price | 304.84 | 225.89 |
Value | 10.18M | 217.67M |
Indicative Equilibrium Price | 302 | 226 |
Indicative Equilibrium Volume | 4 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bintang Mitra Semestaraya Tbk (the Company) was established on November 16, 1989 based on Notarial Deed No. 240 of Mrs Siti Pertiwi Henny Shidki, S.H., which had been amended by Notarial Deed No. 246 dated May 31, 1991 by the same Notary regarding the change of name from PT Bintang Mahkota Semestaraya into PT Bintang Mitra Semestaraya. BMSR is a company that concentrate its business on investing its capital on property companies. It generally invest its capital through subsidiary companies and groups in developing commercial buildings, apartments and general housing.
Read more on BMSR →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →